Suppr超能文献

曲克芦丁(维脑路通)对实验性骨关节炎的影响。

Effects of tribenoside (Glyvenol) on experimental osteoarthrosis.

作者信息

Kalbhen D A, Felten K

出版信息

Pharmacology. 1979;19(2):68-74. doi: 10.1159/000137290.

Abstract

An experimental model of chemically induced osteoarthrosis in the knee joint of adult hens was used to investigate the possible anti-arthrotic potency of the D-glucofuranose derivative tribenoside (Glyvenol). Development and intensity of progressing degenerative processes in the articular tissue were controlled and quantitatively determined by radiographic and macroscopic methods. Tribenoside was given in daily oral doses of 50 and 150 mg/kg by cannulation into the crop. Control of the knee joints by X-ray using mammography film as well as joint space measurements were performed at the beginning and 6, 8, 10, and 12 weeks after induction of osteoarthrosis. The results clearly demonstrate that the higher dose (150 mg/kg) of tribenoside had a significant inhibitory influence on the degenerative processes in the knee joints. The obvious anti-arthrotic potency of tribenoside may be explained by the various chondrotropic and vasotropic activities of this drug. The mode of action of tribenoside on connective tissue is discussed in relation and contrast to the inhibitory effect of most anti-inflammatory antirheumatics on anabolic cartilage metabolism.

摘要

采用成年母鸡膝关节化学诱导性骨关节炎实验模型,研究D - 呋喃葡萄糖衍生物曲克芦丁(维脑路通)可能的抗关节炎效力。通过放射学和宏观方法控制并定量测定关节组织中进行性退变过程的发展和强度。通过将曲克芦丁经插管注入嗉囊,每日口服剂量为50和150 mg/kg。在骨关节炎诱导开始时以及诱导后6、8、10和12周,使用乳腺摄影胶片对膝关节进行X线检查并测量关节间隙。结果清楚地表明,较高剂量(150 mg/kg)的曲克芦丁对膝关节的退变过程有显著的抑制作用。曲克芦丁明显的抗关节炎效力可能归因于该药物多种促软骨生长和促血管生成活性。结合并对比大多数抗炎抗风湿药对合成代谢软骨代谢的抑制作用,讨论了曲克芦丁对结缔组织的作用方式。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验